Personalized dosing strategies may be necessary for biologic therapies, especially fixed-dose options like ustekinumab, due ...

Do you know what singers Cyndi Lauper and LeAnn Rimes have in common with actors Jon Lovitz and Jerry Mathers? All four are among the 7.5 million Americans who are ...

In March 2025, SFA Therapeutics announced that two head-to-head preclinical studies of its oral psoriasis therapy candidate, ...

The use of dupilumab for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents. The association between dupilumab and psoriasis was ...

Patients with psoriasis face higher risk for several different types of cancer, according to the results of an international study.

Adults with worse cardiovascular-kidney-metabolic health are at an increased risk of developing psoriasis, especially in those with high genetic risk.

Topicals are often the first-line treatment for psoriasis, but as the condition progresses, you may need to consider systemic treatments to manage your symptoms. Here’s what to know about your options ...

Codex Labs has announced the launch of the first product in a new collection, KĀNGFÙ, that is focused on healing damaged skin ...

United States: Projected CAGR of 5.1%, with market value rising from USD 127.3 billion in 2025 to USD 209.4 billion by 2035, ...

Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, South Korea Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, South Korea Department ...

The FDA has expanded the approval of Tremfya to include pediatric patients 6 years and older weighing at least 40kg for the treatment of moderate to severe plaque PsO and active PsA.

School of Chemistry and Chemical Engineering, Center of Free Electron Laser & High Magnetic Field, Key Laboratory of Structure and Functional Regulation of Hybrid Materials Ministry of Education, Key ...